🇺🇸 Levofloxacin 500 in United States
600 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 600
Most-reported reactions
- Arthralgia — 110 reports (18.33%)
- Pain In Extremity — 89 reports (14.83%)
- Tendonitis — 62 reports (10.33%)
- Myalgia — 56 reports (9.33%)
- Tendon Pain — 55 reports (9.17%)
- Pain — 50 reports (8.33%)
- Gait Disturbance — 49 reports (8.17%)
- Asthenia — 44 reports (7.33%)
- Paraesthesia — 43 reports (7.17%)
- Musculoskeletal Pain — 42 reports (7%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Levofloxacin 500 approved in United States?
Levofloxacin 500 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Levofloxacin 500 in United States?
Dr. Reddy's Laboratories Limited is the originator. The local marketing authorisation holder may differ — check the official source linked above.